哈鐵科技(688459.SH):TEDS圖像智能識別系統經過認證測試,具備推廣銷售條件
格隆匯9月10日丨哈鐵科技(688459.SH)在投資者互動平台表示,公司人工智能技術具體應用在圖像自動識別和巡檢機器人領域,代表產品有TEDS圖像智能識別系統、TFDS圖像智能識別系統、橋樑檢測機器人、動車組底部巡檢機器人。主要利用了大數據和人工智能技術,將TFDS、TEDS設備採集的圖像進行智能識別和應用。其中TFDS圖像智能識別系統已通過國鐵集團技術審查,TEDS圖像智能識別系統經過認證測試,具備推廣銷售條件。橋樑智能檢測機器人正在進行測試。動車組底部巡檢機器人正在優化升級中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.